Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Field Trip Psychedelics is targeting a $16 billion treatment market with its ketamine-assisted psychotherapy clinics.
Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor
The company bolsters its executive team with the addition of an industry leader and experienced entrepreneur
Kevin O’Leary won’t touch cannabis as an investment but he loves the potential of psychedelic drugs. Why?